These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4074445)

  • 21. [Plasma levels of isosorbide dinitrate and its metabolites during intravenous infusion in surgical patients--effect of preoperative administration of isosorbide dinitrate].
    Murakawa T; Hashimoto Y; Sato T; Takagi H; Kushikata T; Araki I; Kou H; Kimura F; Matsuki A
    Masui; 1993 Feb; 42(2):225-32. PubMed ID: 8437354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of intravenous isosorbide-dinitrate.
    Platzer R; Reutemann G; Galeazzi RL
    J Pharmacokinet Biopharm; 1982 Dec; 10(6):575-86. PubMed ID: 7182455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic extraction of isosorbide dinitrate in cardiac patients.
    Morrison RA; Wiegand UW; Jähnchen E; Höhmann D; Kasper W; Meinertz T; Fung HL
    Clin Pharmacol Ther; 1983 Dec; 34(6):724-31. PubMed ID: 6641086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood and tissue levels of [14C]isosorbide dinitrate after oral and intravenous administration to rat.
    Reed DE; Akester JM; Prather JF; Tuckosh JR; McCurdy DH; Yeh C
    J Pharmacol Exp Ther; 1977 Jul; 202(1):32-7. PubMed ID: 874817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
    Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
    Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical effects of isosorbide dinitrate in the transdermal spray (TD Spray Iso Mack) form].
    Vítovec J; Stejfa M; Blaha M; Nĕmcová H; Roubalík P; Spác J
    Vnitr Lek; 1989 Aug; 35(8):758-64. PubMed ID: 2800383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability and pharmacokinetics of a new isosorbide dinitrate spray preparation in healthy volunteers.
    Hutt V; Theodor R; Pabst G; Lutz D; Bonn R; Fritschi E
    Arzneimittelforschung; 1993 Aug; 43(8):842-6. PubMed ID: 8216439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of isosorbide dinitrate, isosorbide-2-nitrate and isosorbide-5-nitrate in renal insufficiency after repeated oral dosage.
    Evers J; Bonn R; Boertz A; Cawello W; Dickmans HA; Weiss M
    Klin Wochenschr; 1989 Mar; 67(6):342-8. PubMed ID: 2709744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma isosorbide dinitrate concentrations and effect after chewable and high-dose, sustained-release formulations.
    Galeazzi RL; Platzer R; Reutemann G
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):387-93. PubMed ID: 6629543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug plasma levels and coronary vasodilation after isosorbide dinitrate chewing capsules.
    Jost S; Rafflenbeul W; Knop I; Bossaller C; Gulba D; Hecker H; Lippolt P; Lichtlen PR
    Eur Heart J; 1989 Nov; 10 Suppl F():137-41. PubMed ID: 2620680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics of 14C-isosorbide dinitrate after administration in various sustained-release formulations].
    Chasseaud LF; Taylor T; Major RM; Taylor IW; Luckow V; Darragh A; Lambe RF
    Arzneimittelforschung; 1983; 33(9):1298-301. PubMed ID: 6685511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
    Geigenberger A; Degen J; Maier-Lenz H
    Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pharmacokinetic model for isosorbidedinitrate, isosorbide-2-mononitrate, and isosorbide-5-mononitrate.
    Smith D; Aldrich W; Dey M; Enever R; Warner R; Weierstall R
    Drug Metab Dispos; 1990; 18(4):429-34. PubMed ID: 1976063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can isosorbide dinitrate oral spray serve as an immediate bridging therapy for a mass cyanide poisoning?
    Lavon O; Rockwood GA; Eisenkraft A
    Clin Toxicol (Phila); 2021 Aug; 59(8):734-739. PubMed ID: 33274646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Isosorbide dinitrate in the treatment of coronary insufficiency].
    Weber S; Touiza K; Guérin F
    Arch Mal Coeur Vaiss; 1992 Apr; 85 Spec No 1():77-80. PubMed ID: 1356330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative antianginal, hemodynamic and pharmacokinetic effects of isosorbide-2-mononitrate and isosorbide dinitrate in the rat].
    Leitold M; Laufen H
    Arzneimittelforschung; 1983; 33(8):1117-21. PubMed ID: 6685489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane permeation-controlled transdermal delivery system design. Influence of controlling membrane and adhesive on skin permeation of isosorbide dinitrate.
    Seki T; Kawaguchi T; Sugibayashi K; Juni K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):740-3. PubMed ID: 2347017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral isosorbide-5-mononitrate: pharmacokinetics and clinical efficacy.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):129-35. PubMed ID: 3557738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.